Literature DB >> 20961626

α-Synuclein and dopamine at the crossroads of Parkinson's disease.

Lara Lourenço Venda1, Stephanie J Cragg, Vladimir L Buchman, Richard Wade-Martins.   

Abstract

α-Synuclein is central to the Lewy body neuropathology of Parkinson's disease (PD), a devastating neurodegenerative disorder characterized by numerous motor and non-motor manifestations. The cardinal motor symptoms are linked to death of dopaminergic neurons in the nigrostriatal pathway. Here we ask why these neurons are preferentially susceptible to neurodegeneration in PD and how α-synuclein is involved. To address these questions we bring together recent findings from genome-wide association studies, which reveal the involvement of α-synuclein gene variants in sporadic PD, with recent studies highlighting important roles for α-synuclein in synaptic transmission and dopaminergic neuron physiology. These latest advances add to our understanding of PD etiology and provide a central link between the genetic findings and neurodegeneration observed in sporadic PD.
Copyright © 2010 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20961626      PMCID: PMC3631137          DOI: 10.1016/j.tins.2010.09.004

Source DB:  PubMed          Journal:  Trends Neurosci        ISSN: 0166-2236            Impact factor:   13.837


  108 in total

1.  Direct binding and functional coupling of alpha-synuclein to the dopamine transporters accelerate dopamine-induced apoptosis.

Authors:  F J Lee; F Liu; Z B Pristupa; H B Niznik
Journal:  FASEB J       Date:  2001-04       Impact factor: 5.191

Review 2.  The environment and Parkinson's disease: is the nigrostriatal system preferentially targeted by neurotoxins?

Authors:  Donato A Di Monte
Journal:  Lancet Neurol       Date:  2003-09       Impact factor: 44.182

3.  Selective loss of nigral dopamine neurons induced by overexpression of truncated human alpha-synuclein in mice.

Authors:  Masaki Wakamatsu; Aiko Ishii; Shingo Iwata; Junko Sakagami; Yuriko Ukai; Mieko Ono; Daiji Kanbe; Shin-ichi Muramatsu; Kazuto Kobayashi; Takeshi Iwatsubo; Makoto Yoshimoto
Journal:  Neurobiol Aging       Date:  2006-12-14       Impact factor: 4.673

4.  Human and mouse alpha-synuclein genes: comparative genomic sequence analysis and identification of a novel gene regulatory element.

Authors:  J W Touchman; A Dehejia; O Chiba-Falek; D E Cabin; J R Schwartz; B M Orrison; M H Polymeropoulos; R L Nussbaum
Journal:  Genome Res       Date:  2001-01       Impact factor: 9.043

5.  Mutation in the alpha-synuclein gene identified in families with Parkinson's disease.

Authors:  M H Polymeropoulos; C Lavedan; E Leroy; S E Ide; A Dehejia; A Dutra; B Pike; H Root; J Rubenstein; R Boyer; E S Stenroos; S Chandrasekharappa; A Athanassiadou; T Papapetropoulos; W G Johnson; A M Lazzarini; R C Duvoisin; G Di Iorio; L I Golbe; R L Nussbaum
Journal:  Science       Date:  1997-06-27       Impact factor: 47.728

6.  Striatal muscarinic receptors promote activity dependence of dopamine transmission via distinct receptor subtypes on cholinergic interneurons in ventral versus dorsal striatum.

Authors:  Sarah Threlfell; Michael A Clements; Tansi Khodai; Ilse S Pienaar; Richard Exley; Jürgen Wess; Stephanie J Cragg
Journal:  J Neurosci       Date:  2010-03-03       Impact factor: 6.167

7.  Effect of alpha-synuclein on the promoter activity of tyrosine hydroxylase gene.

Authors:  Nan Gao; Yao-Hua Li; Xin Li; Shun Yu; Gui-Lian Fu; Biao Chen
Journal:  Neurosci Bull       Date:  2007-01       Impact factor: 5.203

8.  Inhibition of tyrosine hydroxylase expression in alpha-synuclein-transfected dopaminergic neuronal cells.

Authors:  Shun Yu; Xiaohong Zuo; Yaohua Li; Chen Zhang; Ming Zhou; Yu Alex Zhang; Kenji Uéda; Piu Chan
Journal:  Neurosci Lett       Date:  2004-08-26       Impact factor: 3.046

Review 9.  Neuropathology, biochemistry, and biophysics of alpha-synuclein aggregation.

Authors:  Vladimir N Uversky
Journal:  J Neurochem       Date:  2007-07-10       Impact factor: 5.372

10.  High levels of mitochondrial DNA deletions in substantia nigra neurons in aging and Parkinson disease.

Authors:  Andreas Bender; Kim J Krishnan; Christopher M Morris; Geoffrey A Taylor; Amy K Reeve; Robert H Perry; Evelyn Jaros; Joshua S Hersheson; Joanne Betts; Thomas Klopstock; Robert W Taylor; Douglass M Turnbull
Journal:  Nat Genet       Date:  2006-04-09       Impact factor: 38.330

View more
  100 in total

1.  Impaired spatial and working memory in ageing mice with targeted inactivation of α-synuclein gene.

Authors:  V S Kokhan; G I Van'kin; N N Ninkina; T A Shelkovnikova; S O Bachurin
Journal:  Dokl Biol Sci       Date:  2012-01-07

Review 2.  Mitochondrial dysfunction in Parkinson's disease: molecular mechanisms and pathophysiological consequences.

Authors:  Nicole Exner; Anne Kathrin Lutz; Christian Haass; Konstanze F Winklhofer
Journal:  EMBO J       Date:  2012-06-26       Impact factor: 11.598

Review 3.  A possible pathophysiological role of tyrosine hydroxylase in Parkinson's disease suggested by postmortem brain biochemistry: a contribution for the special 70th birthday symposium in honor of Prof. Peter Riederer.

Authors:  Akira Nakashima; Akira Ota; Yoko S Kaneko; Keiji Mori; Hiroshi Nagasaki; Toshiharu Nagatsu
Journal:  J Neural Transm (Vienna)       Date:  2012-05-27       Impact factor: 3.575

4.  Assembly of α-synuclein aggregates on phospholipid bilayers.

Authors:  Zhengjian Lv; Mohtadin Hashemi; Siddhartha Banerjee; Karen Zagorski; Jean-Christophe Rochet; Yuri L Lyubchenko
Journal:  Biochim Biophys Acta Proteins Proteom       Date:  2019-06-19       Impact factor: 3.036

5.  Impaired neurotransmission caused by overexpression of α-synuclein in nigral dopamine neurons.

Authors:  Martin Lundblad; Mickael Decressac; Bengt Mattsson; Anders Björklund
Journal:  Proc Natl Acad Sci U S A       Date:  2012-02-06       Impact factor: 11.205

6.  Effects of impaired membrane interactions on α-synuclein aggregation and neurotoxicity.

Authors:  Daniel Ysselstein; Mehul Joshi; Vartika Mishra; Amy M Griggs; Josephat M Asiago; George P McCabe; Lia A Stanciu; Carol Beth Post; Jean-Christophe Rochet
Journal:  Neurobiol Dis       Date:  2015-04-27       Impact factor: 5.996

7.  Bidirectional Neural Interaction Between Central Dopaminergic and Gut Lesions in Parkinson's Disease Models.

Authors:  Pablo Garrido-Gil; Ana I Rodriguez-Perez; Antonio Dominguez-Meijide; Maria J Guerra; Jose L Labandeira-Garcia
Journal:  Mol Neurobiol       Date:  2018-02-05       Impact factor: 5.590

8.  Synaptic Regulator α-Synuclein in Dopaminergic Fibers Is Essentially Required for the Maintenance of Subependymal Neural Stem Cells.

Authors:  Ana Perez-Villalba; M Salomé Sirerol-Piquer; Germán Belenguer; Raúl Soriano-Cantón; Ana Belén Muñoz-Manchado; Javier Villadiego; Diana Alarcón-Arís; Federico N Soria; Benjamin Dehay; Erwan Bezard; Miquel Vila; Analía Bortolozzi; Juan José Toledo-Aral; Francisco Pérez-Sánchez; Isabel Fariñas
Journal:  J Neurosci       Date:  2017-12-07       Impact factor: 6.167

9.  Time-Resolved Integrative Optical Imaging of Diffusion during Spreading Depression.

Authors:  Jan Hrabe; Sabina Hrabetova
Journal:  Biophys J       Date:  2019-08-30       Impact factor: 4.033

Review 10.  The Role of Sex and Sex Hormones in Neurodegenerative Diseases.

Authors:  Elisabetta Vegeto; Alessandro Villa; Sara Della Torre; Valeria Crippa; Paola Rusmini; Riccardo Cristofani; Mariarita Galbiati; Adriana Maggi; Angelo Poletti
Journal:  Endocr Rev       Date:  2020-04-01       Impact factor: 19.871

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.